(Q33918101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Alexander M Menzies

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Bing Yu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Richard F. Kefford

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Richard Scolyer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Georgina V. Long

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

M S Carlino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

L E Haydu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

A L Hamilton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

C C Ng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

W A Cooper

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

J F Thompson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

S A O'Toole

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

language of work or name

English

0 references

publication date

10 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

292-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.2014.287

20 March 2020

exact match

0 references

cites work

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

A landscape of driver mutations in melanoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Improved survival with MEK inhibition in BRAF-mutated melanoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

NRAS mutation status is an independent prognostic factor in metastatic melanoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Clinical significance of BRAF mutations in metastatic melanoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Determinants of BRAF mutations in primary melanomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Mutations of the BRAF gene in human cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Clinical significance of BRAF mutation in thyroid papillary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Prevalence of BRAF and NRAS mutations in fast-growing melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2014.287

BRAF and NRAS Mutations Are Frequent in Nodular Melanoma but Are not Associated with Tumor Cell Proliferation or Patient Survival

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4102942

Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region

10 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24918823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24918823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24918823

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2014.287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 March 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24918823%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

24918823

1 reference